MCID: IDP010
MIFTS: 58

Idiopathic Generalized Epilepsy malady

Categories: Genetic diseases (common), Neuronal diseases

Aliases & Classifications for Idiopathic Generalized Epilepsy

About this section

Aliases & Descriptions for Idiopathic Generalized Epilepsy:

Name: Idiopathic Generalized Epilepsy 10 12 65
Epilepsy, Generalized 36 24 65
 
Epilepsy, Idiopathic Generalized 47 24
Generalised Epilepsy 10

Characteristics:



Classifications:



External Ids:

Disease Ontology10 DOID:1827
MeSH36 D004829
NCIt42 C3021
UMLS65 C0014548, C0270850

Summaries for Idiopathic Generalized Epilepsy

About this section
Disease Ontology:10 An epilepsy syndrome that is characterised by generalised seizures with no apparent cause which arise from many independent foci (multifocal epilepsies) or from epileptic circuits that involve the whole brain.

MalaCards based summary: Idiopathic Generalized Epilepsy, also known as epilepsy, generalized, is related to generalized epilepsy with febrile seizures plus and epilepsy syndrome, and has symptoms including eeg with spike-wave complexes (>3.5 hz), generalized myoclonic seizures and absence seizures. An important gene associated with Idiopathic Generalized Epilepsy is GABRG2 (Gamma-Aminobutyric Acid Type A Receptor Gamma2 Subunit), and among its related pathways are NCAM1 interactions and Benzodiazepine Pathway, Pharmacodynamics. Affiliated tissues include brain, breast and temporal lobe, and related mouse phenotypes are hearing/vestibular/ear and reproductive system.

Wikipedia:68 Idiopathic generalized epilepsy (IGE) is a group of epileptic disorders that are believed to have a... more...

Related Diseases for Idiopathic Generalized Epilepsy

About this section

Diseases in the Idiopathic Generalized Epilepsy family:

Epilepsy, Idiopathic Generalized 9 Epilepsy Idiopathic Generalized 8
Epilepsy, Idiopathic Generalized 11 Epilepsy, Idiopathic Generalized 3
Epilepsy, Idiopathic Generalized 5 Epilepsy, Idiopathic Generalized 2
Epilepsy, Idiopathic Generalized 7

Diseases related to Idiopathic Generalized Epilepsy via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 61)
idRelated DiseaseScoreTop Affiliating Genes
1generalized epilepsy with febrile seizures plus28.7KCNQ2, KCNQ3, SCN1A
2epilepsy syndrome28.5CACNA1H, CHRNA4, CLCN2, GABRA1, GABRB3, GABRG2
3epilepsy, generalized, with febrile seizures plus, type 528.0CACNB4, CHRNA4, CLCN2, EFHC1, GABRA1, GABRB3
4epilepsy, idiopathic generalized 911.5
5epilepsy, idiopathic generalized 1111.4
6epilepsy, childhood absence 611.4
7epilepsy, idiopathic generalized, suscpetibility to, 1211.2
8epilepsy idiopathic generalized 811.2
9childhood absence epilepsy10.5
10jeavons syndrome10.5
11myopia 810.4CLCN2, GABRG2
12leukoencephalopathy with ataxia10.4CLCN2, GABRG2
13epilepsy, juvenile myoclonic 510.3
14epilepsy with generalized tonic-clonic seizures10.1
15myoclonic epilepsy, juvenile 110.1
16gaba aminotransferase deficiency10.1CACNA1H, CLCN2, EFHC1, GABRA1
17neuronitis10.1
18partial sensory epilepsy10.0GABRG2, KCNQ3
19status epilepticus10.0
20temporal lobe epilepsy10.0
21cerebritis10.0
22myoclonus10.0
23epilepsy, childhood absence 210.0
24photoparoxysmal response 110.0
25epilepsy, juvenile absence 110.0
26epilepsy, childhood absence 510.0
27epileptic encephalopathy, childhood-onset10.0
28kcnq3-related disorders9.9KCNQ2, KCNQ3
29hypothalamic hamartomas with gelastic seizures9.9GABRG2, SCN1A
30myoclonus epilepsy9.9
31brugada syndrome 59.8SCN1A, SCN1B
32olivopontocerebellar atrophy9.7KCNQ2, KCNQ3
33schizophrenia9.7
34obsessive-compulsive disorder9.7
35apraxia9.7
36stuttering9.7
37long qt syndrome9.7
38frontal lobe epilepsy9.7
39narcolepsy9.7
40episodic ataxia9.7
41myoclonic astatic epilepsy9.7
42ataxia9.7
43febrile seizures9.7
44perioral myoclonia with absences9.7
45scn9a-related inherited erythromelalgia9.7SCN1A, SCN1B
46pulmonary valve insufficiency9.6KCNQ2, KCNQ3
47haemonchiasis9.6CHRNA4, KCNQ2, KCNQ3
48nonsyndromic deafness9.4GABRA1, KCNQ2, SCN1A
49infancy electroclinical syndrome9.2KCNQ2, KCNQ3, SCN1A
50prothrombin deficiency9.2CHRNA4, GABRD, GABRG2, SCN1A

Graphical network of the top 20 diseases related to Idiopathic Generalized Epilepsy:



Diseases related to idiopathic generalized epilepsy

Symptoms for Idiopathic Generalized Epilepsy

About this section

HPO human phenotypes related to Idiopathic Generalized Epilepsy:

id Description Frequency HPO Source Accession
1 eeg with spike-wave complexes (>3.5 hz) HP:0010849
2 generalized myoclonic seizures HP:0002123
3 absence seizures HP:0002121
4 generalized tonic-clonic seizures HP:0002069

UMLS symptoms related to Idiopathic Generalized Epilepsy:


convulsion in childhood, seizures, focal, myoclonus, eyelid, non-epileptic convulsion, seizures, tonic, epileptic aura, seizures

Drugs & Therapeutics for Idiopathic Generalized Epilepsy

About this section

Drugs for Idiopathic Generalized Epilepsy (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 219)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Pregabalinapproved, illicit, investigationalPhase 4, Phase 3340148553-50-85486971
Synonyms:
(3S)-3-(aminomethyl)-5-methylhexanoic acid
(R-)-3-isobutyl GABA
(S)-3-(Aminomethyl)-5-methylhexanoic acid
(S)-3-Isobutyl gaba
(S+)-3-isobutyl GABA
121GE001
148553-50-8
3-Isobutyl gaba
3-isobutyl GABA
AC-1158
AC1NUP03
AKOS005145504
C080245
C8H17NO2
CHEBI:236161
CHEMBL1059
CI 1008
CI-1008
CID5486971
 
D02716
DB00230
FT-0080911
HSDB 7530
LS-75191
Lyrica
Lyrica (TN)
MolPort-000-861-733
PD 144723
PD-144723
Pregabalin
Pregabalin (JAN/USAN/INN)
Pregabalin [USAN]
Pregablin
S-(+)-3-isobutylgaba
S1731_Selleck
SBB062901
TL8001062
TOS-BB-0910
UNII-55JG375S6M
2
DopamineapprovedPhase 4, Phase 2308462-31-7, 51-61-6681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine Hcl
Dopamine Hydrochloride
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
 
KBio1_000780
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
3
TiagabineapprovedPhase 420115103-54-360648
Synonyms:
(-)-(R)-1-(4,4-Bis(3-methyl-2-thienyl)-3-butenyl)nipecotic acid
(3R)-1-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]piperidine-3-carboxylic acid
(3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-enyl]piperidine-3-carboxylic acid
115103-54-3
A-70569-1
ABBOTT-70569-1
AC-7048
AC1L1TNE
AC1Q5R43
BIDD:GT0018
C07503
C20H25NO2S2
CHEBI:222170
CHEMBL1027
CID60648
D08588
DB00906
 
Gabitril
Gabitril (TN)
HSDB 7527
LS-114651
N-(4,4-di(3-methylthien-2-yl)but-3-enyl)nipecotic acid
NCGC00164626-01
NO 329
NO-328
NO-329
Tiagabina
Tiagabina [INN-Spanish]
Tiagabine (INN)
Tiagabine [INN:BAN]
Tiagabine [INN]
Tiagabinum
Tiagabinum [INN-Latin]
UNII-Z80I64HMNP
tiagabine
4
Zonisamideapproved, investigationalPhase 4, Phase 36568291-97-45734
Synonyms:
1,2-Benzisoxazole-3-methanesulfonamide
1,2-benzoxazol-3-ylmethanesulfonamide
1-(1,2-Benzoxazol-3-Yl)methanesulfonamide
1-(1,2-benzisoxazol-3-yl)methanesulfonamide
3-(Sulfamoylmethyl)-1,2-benzisoxazole
3-sulfamoylmethyl-1,2-benzisoxazole
68291-97-4
AC-1413
AC1L1L0Q
AC1Q55GQ
AD 810
AD-810
AD-810N
AKOS001312269
BIDD:GT0708
BIDD:PXR0183
BRD-K48300629-001-03-8
BRN 1077076
Benzo[D]isoxazol-3-yl-methanesulfonamide
Bio-0532
C022189
C07504
C8H8N2O3S
CHEBI:10127
CHEMBL750
CI 912
CI-912
CID5734
CPD000596519
D00538
DB00909
E-2090
Elan brand of zonisamide
Exceglan
 
Excegram
Excegran
Excegran (TN)
FT-0082702
HMS2089O07
HSDB 7293
I06-0495
LS-33637
MLS001195632
MLS001306491
MolPort-002-507-855
NCGC00159319-02
NCGC00159319-03
PD 110843
PD-110843
S1445_Selleck
SAM002548957
SMR000596519
SPR_2
STK711131
Tremode
Trerief
UNII-459384H98V
ZINC00004321
Zonegran
Zonegran, Zonisamide
Zonisamida
Zonisamida [Spanish]
Zonisamide
Zonisamide (JAN/USAN/INN)
Zonisamide (ZNS)
Zonisamide [USAN:BAN:INN:JAN]
Zonisamidum
Zonisamidum [Latin]
zonisamide
zonisamide monosodium
5
SertralineapprovedPhase 428279617-96-268617
Synonyms:
(+)-Sertraline
(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine
(1S,4S)-Sertraline
(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine
(1S-cis)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine
79559-97-0 (Hydrochloride)
79617-96-2
AB00514002
AB1004870
AC-15639
AC1L2A41
AC1Q3O5N
AC1Q3XJU
Apo-Sertraline
BIDD:GT0768
BIDD:PXR0193
BPBio1_001285
BRD-K82036761-003-02-1
BRN 5753709
BSPBio_001167
BSPBio_002698
C07246
C17H17Cl2N
CHEBI:9123
CHEMBL809
CID68617
CP 51974
Cp 51974
D02360
DB01104
DB08567
FT-0081122
HSDB 7037
KBio3_001918
 
KBioGR_001724
LS-94179
Lustral
MLS001195647
MLS002222308
MolPort-002-885-860
NCGC00092386-03
NCGC00092386-04
NCGC00092386-05
NCGC00092386-06
NCGC00092386-07
NCGC00092386-08
NCGC00092386-09
Prestwick3_001014
SMR000596516
SPBio_000385
SRE
Sertralina
Sertralina [Spanish]
Sertraline
Sertraline (INN)
Sertraline Hydrochloride
Sertraline [INN:BAN]
Sertraline [Zoloft]
Sertraline hydrochloride
Sertralinum
Sertralinum [Latin]
Spectrum2_000493
Spectrum3_001079
Spectrum4_001232
Sultamicillin Tosylate
UNII-QUC7NX6WMB
Zoloft
cis-(+)-Sertraline
sertraline
sertraline (Zoloft)
6
Gabapentinapproved, investigationalPhase 426960142-96-33446
Synonyms:
1-(Aminomethyl)-cyclohexaneacetic acid
1-(Aminomethyl)cyclohexaneacetic acid
2-[1-(aminomethyl)cyclohexyl]acetic acid
60142-96-3
AC-1485
AC1L1FYE
AC1Q53PH
AKOS000280865
Aclonium
Apo-Gabapentin
Apotex brand of gabapentin
Aventis brand of gabapentin
BB_SC-1512
BIDD:GT0656
BPBio1_000993
BRN 2359739
BSPBio_000901
C040029
C9H17NO2
CAS-60142-96-3
CCRIS 7210
CHEBI:188316
CHEBI:42797
CHEMBL940
CI 945
CI-945
CID3446
D00332
DB00996
DDS-2003
DM-1796
DM-5689
EINECS 262-076-3
EU-0100582
G-154
G0318
G154_SIGMA
GBN
GOE 2450
Gabapen
Gabapentin
Gabapentin (JAN/USAN/INN)
Gabapentin GR
Gabapentin Hexal
Gabapentin Kit
Gabapentin Stada
Gabapentin [USAN:INN:BAN]
Gabapentin-ratiopharm
Gabapentina
Gabapentine
Gabapentine [INN-French]
Gabapentino
Gabapentino [INN-Spanish]
Gabapentino [Spanish]
Gabapentinum
 
Gabapentinum [INN-Latin]
Gabapetin
Go 3450
Goe-3450
Gralise
Gralise Starter Pack
HMS1570N03
HMS2089J03
HSDB 7364
Hexal brand of gabapentin
I06-0677
L000733
LS-7194
Lopac-G-154
Lopac0_000582
MLS000069358
MolPort-000-883-862
NCGC00015466-01
NCGC00015466-02
NCGC00015466-06
NCGC00015466-09
NCGC00016891-01
NCGC00021545-02
NCGC00021545-04
NCGC00021545-05
NSC742194
Neurontin
Neurontin (TN)
Novo-Gabapentin
Novo-Gabapentine
Novopharm brand of gabapentin
PMS-Gabapentin
Parke Davis brand of gabapentin
Pfizer brand of gabapentin
Pharmascience brand of gabapentin
Prestwick0_000861
Prestwick1_000861
Prestwick2_000861
Prestwick3_000861
Prestwick_151
S2133_Selleck
SMR000058311
SPBio_002822
STK598009
Serada
Stadapharm brand of gabapentin
TL8003814
Tocris-0806
UNII-6CW7F3G59X
Vultin
Warner-Lambert brand of gabapentin
[1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID
gabapentin
gabapentin (Neurontin)
gabapentina
gabapentinium
ratiopharm brand of gabapentin
7
ClevidipineapprovedPhase 420166432-28-6
Synonyms:
 
Clevidipine butyrate
Cleviprex
8
OxcarbazepineapprovedPhase 4, Phase 2, Phase 35428721-07-534312
Synonyms:
10,11-Dihydro-10-oxo-5H-debenz(b,f)azepine-5-carboxamide
10,11-Dihydro-10-oxo-5H-dibenz(b,F)azepine-5-carboxamide
10,11-Dihydro-10-oxo-5H-dibenz(b,f)azepine-5-carboxamide
10,11-Dihydro-10-oxo-5H-dibenzo[b,f]azepine-5-carboxamide
10,11-Dihydro-10-oxo-5h-dibenz[b,f]azepine-5-carboxamide
10-Oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide
28721-07-5
5-oxo-6H-benzo[b][1]benzazepine-11-carboxamide
AB1004555
AC-3483
AC1L1RCU
AC1Q6NA8
BIDD:GT0078
BSPBio_003457
Bio-0527
C036006
C07492
CHEMBL1068
CID34312
CPD000048684
D00533
DB00776
Desitin brand of oxcarbazepine
EINECS 249-188-8
Epilexter
Epliga
GP 47680
GP-47680
HMS1922H17
HMS2051O04
HMS2090F13
HMS2093E10
HSDB 7524
I06-0072
KBio2_002155
KBio2_004723
KBio2_007291
KBio3_002677
KBioGR_001248
KBioSS_002155
KIN-493
 
LS-60365
MLS000084586
MLS000759520
MLS001201742
MolPort-001-685-316
NCGC00065934-02
NCGC00065934-03
NCGC00065934-04
Novartis brand of oxcarbazepine
O0363
O3764_SIGMA
OCBZ
OXCARBAZEPINE
Oxacarbazepine
Oxcarbamazepine
Oxcarbazepime
Oxcarbazepina
Oxcarbazepina [INN-Spanish]
Oxcarbazepine
Oxcarbazepine (USAN/INN)
Oxcarbazepine [INN]
Oxcarbazepinum
Oxcarbazepinum [INN-Latin]
Oxtellar Xr
S1391_Selleck
SAM001246754
SMR000048684
SPBio_000345
SPECTRUM1504243
SPN-804
STK594696
Spectrum2_000483
Spectrum3_001669
Spectrum4_000634
Spectrum5_001869
Spectrum_001675
Timox
Trileptal
Trileptal (TN)
UNII-VZI5B1W380
ZINC00004724
oxcarbazepine
9
HydralazineapprovedPhase 44286-54-43637
Synonyms:
(1Z)-1(2H)-Phthalazinone hydrazone
(2H)-Phthalazinone hydrazone
1(2H)-Phthalazinone hydrazone
1(2H)-Phthalazinone, hydrazone
1-Hydrazinophthalazine
1-Phthalazinylhydrazine
304-20-1 (mono-hydrochloride)
5-25-17-00412 (Beilstein Handbook Reference)
6-Hydralazine
86-54-4
AC1L1GDN
AC1Q4UY1
AKOS000122609
Apresolin
Apresoline
Apressin
Apressin (pharmaceutical)
Apressoline
Aprezolin
BA 5968
BRD-K82103381-003-03-7
BRN 0132615
BSPBio_002130
C 5968
C-5068
C-5968
C07040
C8H8N4
CAS-304-20-1
CCRIS 5385
CHEBI:5775
CHEMBL276832
CID3637
Ciba 5968
D08044
DB01275
DivK1c_000117
EC-000.1838
EINECS 201-680-3
HLZ
Hidral
Hidral (TN)
Hidralazin
Hidralazina
Hidralazina [INN-Spanish]
Hidralazina [Spanish]
Hipoftalin
Hydralazin
Hydralazine
Hydralazine (INN)
Hydralazine Hydrochloride
Hydralazine [INN:BAN]
 
Hydralazine hydrochloride
Hydralazinum
Hydralazinum [INN-Latin]
Hydrallazin
Hydrallazine
Hydrazinophthalazine
Hydrazone 1(2H)-phthalazinone
Hypophthalin
IDI1_000117
Idralazina
Idralazina [DCIT]
Idralazina [Italian]
InChI=1/C8H8N4/c9-11-8-7-4-2-1-3-6(7)5-10-12-8/h1-5H,9H2,(H,11,12)
KBio1_000117
KBio2_001355
KBio2_003923
KBio2_006491
KBio3_001350
KBioGR_000349
KBioSS_001355
LS-109171
Lopac-H-1753
Lopac0_000593
MolPort-000-876-738
MolPort-001-794-088
NCGC00015501-01
NCGC00015501-02
NCGC00015501-05
NCGC00162199-01
NCIOpen2_001484
NINDS_000117
NSC 126699
NSC126699
Oprea1_207681
Oprea1_416878
Phthalazin-1-ylhydrazine
Praparat 5968
Prestwick0_000169
Prestwick1_000169
Prestwick2_000169
SPBio_000977
SPBio_001958
ST50512087
Spectrum2_000969
Spectrum3_000455
Spectrum4_000005
Spectrum5_000822
Spectrum_000875
UNII-26NAK24LS8
WLN: T66 CNNJ BMZ
ZINC12360535
[2H-Phthalazin-(1Z)-Ylidene]-Hydrazine Hydrochloride
hydralazine
phthalazin-1-ylhydrazine
10
LabetalolapprovedPhase 43036894-69-63869
Synonyms:
2-Hydroxy-5-(1-hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)benzamide
2-hydroxy-5-[1-hydroxy-2-(4-phenylbutan-2-ylamino)ethyl]benzamide
2-hydroxy-5-{1-hydroxy-2-[(1-methyl-3-phenylpropyl)amino]ethyl}benzamide
3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol
36894-69-6
5-(1-Hydroxy-2-(1-methyl-3-phenylpropylamino)ethyl)salicylamide
AB00053659
AC-18747
AC1L1GW8
AH 5158
AH-5158
Albetol
BPBio1_000170
BRD-A07440155-003-05-6
BSPBio_000154
BSPBio_003142
C07063
CHEBI:6343
CHEMBL429
CID3869
D08106
DB00598
DivK1c_000474
EINECS 253-258-3
HSDB 6537
IDI1_000474
Ibidomide
KBio1_000474
KBio2_002087
KBio2_004655
KBio2_007223
KBio3_002642
 
KBioGR_000727
KBioSS_002087
L001344
LS-26936
Labetalol
Labetalol (INN)
Labetalol Hydrochloride
Labetalol [INN:BAN]
Labetalolum
Labetalolum [INN-Latin]
Labetolol
Lopac0_000687
MolPort-003-898-140
NCGC00015595-06
NCGC00089800-02
NINDS_000474
NORMOZIDE
Prestwick0_000277
Prestwick1_000277
Prestwick2_000277
Prestwick3_000277
SBB067266
SPBio_000905
SPBio_002373
Sch-19927
Spectrum2_000863
Spectrum3_001581
Spectrum4_000184
Spectrum5_001010
Spectrum_001607
TL8002725
Trandate
UNII-R5H8897N95
labetalol
11
Methylphenidateapproved, investigationalPhase 4364113-45-14158
Synonyms:
.alpha.-Phenyl-2-piperidineacetic acid methyl ester
113-45-1
2-Piperidineacetic acid, .alpha.-phenyl-, methyl ester
2-Piperidineacetic acid, alpha-phenyl-, methyl ester
298-59-9 (hydrochloride)
4311/B Ciba
AC1L1HJM
C 4311
C07196
CHEBI:6887
CHEMBL796
CID4158
Calocain
Centedein
Centedrin
Centedrine
Centredin
Concerta
D-Methylphenidate HCl
D04999
DB00422
DB06701
DEA No. 1724
Daytrana
Daytrana (TN)
EINECS 204-028-6
Focalin
Focalin XR
HSDB 3126
L001307
LS-565
METHYLPHENIDATE (SEE ALSO: METHYLPHENIDATE HYDROCHLORIDE, CAS 298-59-9, NTPNO 10266-R)
MPH
Meridil
Metadate
Metadate CD
Metadate ER
MethyPatch
Methyl (2-phenyl-2-(2-piperidyl)acetate)
Methyl alpha-phenyl-alpha-(2-piperidyl)acetate
Methyl alpha-phenyl-alpha-2-piperidinylacetate
Methyl phenidate
Methyl phenidyl acetate
 
Methyl phenidylacetate
Methylfenidan
Methylin
Methylin ER
Methylofenidan
Methylphen
Methylphenidan
Methylphenidate
Methylphenidate (USAN/INN)
Methylphenidate HCl
Methylphenidate Hydrochloride
Methylphenidate [INN:BAN]
Methylphenidate hydrochloride
Methylphenidatum
Methylphenidatum [INN-Latin]
Methylphenidylacetate hydrochloride
Methypatch
Metilfenidat hydrochloride
Metilfenidato
Metilfenidato [INN-Spanish]
Metilfenidato [Italian]
MolPort-001-779-620
NCI-C56280
PMS-Methylphenidate
Phenidylate
Plimasine
Quillivant XR
Riphenidate
Ritalin
Ritalin LA
Ritalin SR
Ritalin hydrochloride
Ritalin-SR
Ritaline
Ritcher Works
Ritcher works
Tsentedrin
UNII-207ZZ9QZ49
alpha-Phenyl-2-piperidineacetic acid methyl ester
alpha-Phenyl-alpha-(2-piperidyl)acetic acid methyl ester
d-methylphenidate HCl
methyl 2-phenyl-2-piperidin-2-ylacetate
methyl phenyl(piperidin-2-yl)acetate
methylphenidate
nchembio.2007.55-comp28
12
Carbamazepineapproved, investigationalPhase 4, Phase 3, Phase 2118298-46-42554
Synonyms:
2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene-2-carboxamide
298-46-4
5-Carbamoyl-5H-dibenz(b,f)azepine
5-Carbamoyl-5H-dibenz[b,F]azepine
5-Carbamoyl-5H-dibenz[b,f]azepine
5-Carbamoyl-5H-dibenzo(b,F)azepine
5-Carbamoyl-5H-dibenzo(b,f)azepine
5-Carbamoyldibenzo(b,f)azepine
5-Carbamyl-5H-dibenzo(b,F)azepine
5-Carbamyl-5H-dibenzo(b,f)azepine
5-Carbamyldibenzo(b,f)azepine
5H-Dibenz(b,F)azepine-5-carboxamide
5H-Dibenz(b,f)azepine-5-carboxamide
5H-Dibenz[b,f]azepine-5- carboxamide
5H-Dibenz[b,f]azepine-5-carboxamide
5H-Dibenzo[b,f]azepine-5-carboxamide
85756-57-6 (di-hydrate)
AC-10560
AC1L1DXT
AC1Q4ZSU
AC1Q4ZSV
AKOS003235644
Amizepin
Amizepine
Apo-Carbamazepine
Atretol
BIDD:GT0479
BIM-0050280.0001
BPBio1_000225
BRD-K71799949-001-06-7
BRN 1246090
BSPBio_000203
BSPBio_001929
Bio-0751
Bipotrol
Biston
C 4024
C06868
C4024_SIAL
C4024_SIGMA
C8981_SIAL
CARBAMAZEPINE, U.S.P.
CAS-298-46-4
CBChromo1_000350
CBZ
CDS1_002710
CHEBI:3387
CHEMBL108
CID2554
CPD001227191
Calepsin
Carbamazepan
Carbamazepen
Carbamazepin
Carbamazepina
Carbamazepina [INN-Spanish]
Carbamazepine
Carbamazepine (JP15/USP/INN)
Carbamazepine ER
Carbamazepine [USAN:INN:BAN:JAN]
Carbamazepinum
Carbamazepinum [INN-Latin]
Carbamazépine
Carbamezepine
Carbatrol
Carbatrol extended-release
Carbazepin
Carbazepine
Carbelan
ChemDiv1_018966
D00252
DB00564
DivK1c_000388
DivK1c_003750
EINECS 206-062-7
EU-0100292
Epitol
Epitol, Equetro, Tegretol, Biston, Calepsin, Carbamazepine
Equetro
Equetro (TN)
Finlepsin
G 32883
G-32883
Geigy 32883
HMS1568K05
 
HMS1920I17
HMS2090M07
HMS2091O19
HMS501D10
HMS640O02
HSDB 3019
I06-0863
IDI1_000388
KBio1_000388
KBio2_000516
KBio2_003084
KBio2_005652
KBio3_001149
KBioGR_000724
KBioSS_000516
Karbamazepin
LS-60362
Lexin
Lopac-C-4024
Lopac0_000292
MLS000069652
MLS001055475
MLS001074172
Mazepine
MolPort-000-710-574
NCGC00015234-01
NCGC00015234-02
NCGC00015234-03
NCGC00015234-07
NCGC00015234-13
NCGC00023877-03
NCGC00023877-04
NCGC00023877-05
NCGC00023877-06
NCGC00023877-07
NCGC00023877-08
NINDS_000388
NSC 169864
NSC169864
Neurotol
Neurotop retard
Novo-Carbamaz
Nu-Carbamazepine
Oprea1_790775
Prestwick0_000052
Prestwick1_000052
Prestwick2_000052
Prestwick3_000052
Prestwick_104
S1693_Selleck
SAM002264603
SMR000058201
SMR001227191
SPBio_000170
SPBio_002124
SPD-417
SPECTRUM1500159
STK177357
Sirtal
Spectrum2_000125
Spectrum3_000325
Spectrum4_000262
Spectrum5_000936
Spectrum_000096
Stazepin
Stazepine
Taro-Carbamazepine
Taro-Carbamazepine Cr
Tegretal
Tegretol
Tegretol (TN)
Tegretol Chewtabs
Tegretol Cr
Tegretol XR
Tegretol-Xr
Telesmin
Teril
Timonil
Trimonil
UNII-33CM23913M
WLN: T C676 BNJ BVZ
ZINC00004785
benzo[b][1]benzazepine-11-carboxamide
carbamazepine
carbamazepine (Tegretol)
nchem.859-comp7
13
TopiramateapprovedPhase 4, Phase 3, Phase 2, Phase 124097240-79-45284627
Synonyms:
-D-fructopyranose deriv.
.beta.-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, sulfamate (9CI)
2,3-4,5-bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene) .beta.-D-fructopyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-36-D-fructo-pyranose sulfamate
2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate
2,3:4,5-Di- O -isopropylidene-(beta)-D-fructopyranose sulfamate
2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate
5H-Bis[1,3]dioxolo[4,5-b:4',5'-d]pyran, .beta.
97240-79-4
AKOS000424547
BIDD:GT0854
BIDD:PXR0127
BRN 5988957
BSPBio_002306
C052342
C07502
C12H21NO8S
CBChromo1_000352
CHEBI:129573
CHEMBL220492
CID5284627
CPD000466325
Cilag brand of topiramate
D00537
DB00273
Epitoma
Epitomax
HMS1922H06
HMS2051L09
HMS2093D20
HSDB 7531
Janssen brand of topiramate
KS-1122
KW-6485
LS-187392
LS-69764
MLS000759431
MLS001424070
McN 4853
McN-4853
MolPort-001-615-062
MolPort-002-885-869
NCGC00178714-01
Ortho brand of topiramate
 
Qudexy XR
RWJ 17021
RWJ-17021
RWJ-17021-000
S1438_Selleck
SAM001246601
SMR000466325
SPBio_000995
SPECTRUM1505801
STOCK1N-71037
Spectrum2_001128
T0575_SIGMA
TL8006021
TOR
TPM
Tipiramate
Tipiramate [French]
Tipiramato
Tipiramato [Spanish]
Topamac
Topamax
Topamax (TN)
Topamax Sprinkle
Topamax, Topiramate
Topimax
Topina
Topiramate
Topiramate (JAN/USAN/INN)
Topiramate (TPM)
Topiramate / Placebo
Topiramate [USAN:BAN:INN]
Topiramato
Topiramato [INN-Spanish]
Topiramatum
Topiramatum [INN-Latin]
Topiramic acid
Topomax
Trokendi Xr
UNII-0H73WJJ391
USL-255
[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl]methyl sulfamate
beta-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, sulfamate
beta.-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, 1-sulfamate
topiramate
topiramate tablet
topiramatum [Latin]
14
Valproic Acidapproved, investigationalPhase 4, Phase 3, Phase 231199-66-13121
Synonyms:
(N-C3H7)2CHCOOH
(S)-2-propyl-4-pentanoate
(S)-2-propyl-4-pentanoic acid
2 PP (base)
2-N-Propyl-N-valeric acid
2-PROPYL-pentanoic acid
2-Propyl-Pentanoate
2-Propyl-Pentanoic acid
2-Propylpentanoate
2-Propylpentanoic Acid
2-Propylpentanoic acid
2-Propylvaleric Acid
2-Propylvaleric acid
2-n-Propyl-n-valeric acid
2-n-propyl-n-valeric acid
2-propylvaleric acid
4-Heptanecarboxylic acid
4-heptanecarboxylic acid
76584-70-8 (hydrochloride salt (2:1))
99-66-1
AC1L1F7T
AC1Q2ULA
AI3-10500
APO-divalproex
Abbott 44090
Acide valproique
Acide valproique [INN-French]
Acide valproique [inn-french]
Acido valproico
Acido valproico [INN-Spanish]
Acido valproico [inn-spanish]
Acidum valproicum
Acidum valproicum [INN-Latin]
Acidum valproicum [inn-latin]
Alti-Valproic
Alti-valproic
Apo-valproic
Apo-valproic syrup
Avugane
BIDD:GT0858
BRN 1750447
Baceca
C07185
CHEBI:39867
CHEMBL109
CID3121
CPD000499581
Convulex
Convulsofin
D00399
DB00313
DOM-divalproex
DOM-valproic
DOM-valproic acid E.C.
DPA
Delepsine
Depacon
Depakene
Depakene (TN)
Depakin
Depakin chrono
Depakine
Depakine chrono
Depakote
Depakote (TM)
Depakote ER
Deproic
Di-N-propylacetic acid
Di-N-propylessigsaeure
Di-N-propylessigsaure
Di-N-propylessigsaure [german]
Di-n-propylacetic acid
Di-n-propylessigsaeure
Di-n-propylessigsaure
Di-n-propylessigsaure [German]
Di-n-propylessigsäure
Dipropyl Acetate
Dipropylacetate
Dipropylacetic acid
DivK1c_000273
Divalproex
Dom-Valproic
Dom-valproate
Dom-valproic acid
Dom-valproic acid syrup
EINECS 202-777-3
Epiject I.V.
Epilex
Epilim
Epival
Epival er
Ergenyl
G2M-777
Gen-divalproex
HMS2089J06
HSDB 3582
I04-0211
InChI=1/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)
KBio1_000273
KBio2_001001
KBio2_002277
KBio2_003569
KBio2_004845
 
KBio2_006137
KBio2_007413
KBio3_002626
KBio3_002757
KBioGR_000871
KBioGR_002277
KBioSS_001001
KBioSS_002278
Kyselina 2-propylvalerova
Kyselina 2-propylvalerova [Czech]
LS-161170
LS-2068
MLS001076682
MLS001335927
MLS001335928
MLS002415770
Med Valproic
Med valproic
MolPort-001-791-895
Mylproin
Myproate
Myproic Acid
Myproic acid
N-DPA
N-Dipropylacetic acid
NCGC00091149-01
NCGC00091149-02
NCGC00091149-03
NCGC00091149-04
NINDS_000273
NSC 93819
NSC93819
Novo-Valproic
Novo-Valproic - ECC
Novo-divalproex
Novo-valproic
Novo-valproic soft gel cap
Nu-Valproic
Nu-valproic
P0823
P6273_SIGMA
PEAC
PHL-valproate
PHL-valproic acid
PHL-valproic acid E.C.
PMS-Divalproex
PMS-Valproic Acid
PMS-valproate
PMS-valproic acid
PMS-valproic acid E.C.
Penta-Valproic
Penta-valproic
Propylvaleric acid
Ratio-Valproic - ECC
S(-)-4-En-valproate
S(-)-4-En-valproic acid
S-2-N-Propyl-4-pentenoate
S-2-N-Propyl-4-pentenoic acid
SAM002564230
SBB065764
SMR000499581
SPBio_000912
Sandoz valproic
Savicol
Semisodium Valproate
Sodium hydrogen divalproate
Spectrum2_000946
Spectrum3_001733
Spectrum4_000376
Spectrum_000521
Sprinkle
Stavzor
UNII-614OI1Z5WI
VALPROIC ACID
VALPROIC acid
VPA
Valcote
Valparin
Valproate
Valproate Semisodium
Valproate semisodique [French]
Valproate semisodium
Valproato semisodico [Spanish]
Valproatum seminatricum [Latin]
Valproic
Valproic Acid
Valproic Acid, Sodium Salt (2:1)
Valproic acid
Valproic acid (USP)
Valproic acid USP
Valproic acid USP24
Valproic acid [USAN:INN:BAN]
Valproic acid [usan:ban:inn]
Valproinsaeure
Valproinsäure
Vupral
WLN: QVY3 & 3
di-n-propylacetic acid
n-DPA
n-Dipropylacetic acid
nchembio.79-comp4
nchembio815-comp21
valproate
valproic acid
15
CitalopramapprovedPhase 449459729-33-82771
Synonyms:
1,3-Dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-5-isobenzofurancarbonitrile
1,3-dihydro[3,4]benzofuran-5-carbonitrile
1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile
59729-33-8
AB00513896
AC-12214
AC1L1EFH
AE-641/00603021
Akarin
BPBio1_000929
BRD-A47598013-004-02-0
BSPBio_000843
Bonitrile
C07572
C20H21FN2O
CHEBI:3723
CHEMBL549
CID2771
CPD000465669
Celapram
Celexa
Celius
Ciazil
Cilift
Cipram
Cipramil
Ciprapine
Citabax
Citadur
Citadur (TN)
Citalec
Citalopram
Citalopram (USP/INN)
Citalopram Hydrobromide
Citalopram [Celexa]
Citalopram [INN:BAN]
Citalopram hydrobromide
Citalopramum
Citalopramum [INN-Latin]
 
Citol
Citopam
Citox
Citrol
Cytalopram
D07704
DB00215
Dalsan
EINECS 261-891-1
Elopram
HMS2090O09
HMS2093A14
Humorup
I01-0382
InChI=1/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3
L001223
LS-84327
Lopac0_000258
Lu 10-171
Lu-10-171
MolPort-003-666-794
NCGC00015267-07
NCGC00025160-02
Nitalapram
Oropram
Perrigo Citalopram
Pramcit
Prestwick3_000692
Recital
SAM002589960
ST069372
STL058639
Seropram
Talam
Talohexal
Temperax
UNII-0DHU5B8D6V
Vodelax
Zentius
Zetalo
[3H]Citalopram
citalopram
16
Midazolamapproved, illicitPhase 4, Phase 3, Phase 2, Phase 163559467-70-84192
Synonyms:
4H-Imidazo[1,5-a][1,4]benzodiazepine, 8-chloro-6-(2-fluoro-phenyl)-1-methyl-, (Z)-2-butenedioate
59467-70-8
8-Chlor-6-(2-fluorphenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepin
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine
8-Chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5a][1,4]benzodiazepine hydrochloride
8-Chloro-6-(O-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]-benzodiazepine
8-Chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepine
AC-18749
AC1L1HMA
BIDD:GT0647
BRN 0625572
Buccolam
C07524
C18H13ClFN3
CHEMBL655
CID4192
D00550
DB00683
DEA No. 2884
Dazolam
Dea No. 2884
Dormicum
 
Dormicum (TN)
EINECS 261-774-5
LS-77780
Midanium
Midazolam
Midazolam (JAN/INN)
Midazolam Base
Midazolam Hcl
Midazolam Hydrochloride
Midazolam [INN:BAN:JAN]
Midazolamum
Midazolamum [INN-Latin]
Midosed
MolPort-003-849-219
NCGC00168254-01
Ro 21-3981
TL8003787
UC429_SIGMA
UNII-R60L0SM5BC
Versed
ZINC00001732
midazolam
nchembio747-comp32
17
Clonazepamapproved, illicitPhase 4, Phase 3261622-61-32802
Synonyms:
1,3-Dihydro-5-(o-chlorophenyl)-7-nitro-3H-1,4-benzodiazepin-2-one
1,3-Dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one
1,3-dihydro-7-Nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one
106955-87-7
1622-61-3
5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one
5-(2-Chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one
5-(2-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one
5-(2-Chlorophenyl)-7-nitro-3H-1,4-benzodiazepin-2(1H)-one
5-(2-chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one
5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
5-(o-Chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one
5-(o-Chlorophenyl)-7-nitro-1H-1,4-benzodiazepin-2(3H)-one
5-(o-chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one
5-24-04-00351 (Beilstein Handbook Reference)
7-Nitro-5-(2-chlorophenyl)-3H-1,4-benzodiazepin-2(1H)-one
AC-15733
AC1L1EI2
Alti-Clonazepam
Antelepsin
Antilepsin
BAS 00308658
BIDD:PXR0144
BRN 0759557
C1277_SIGMA
C15H10ClN3O3
CHEBI:3756
CHEMBL452
CID2802
CLONAZEPAM
Chlonazepam
Cloazepam
Clonazepam
Clonazepam (JP15/USP/INN)
Clonazepam [USAN:INN:BAN:JAN]
Clonazepamum
Clonazepamum [INN-Latin]
Clonex
Clonopin
D00280
D002998
DB01068
 
DEA No. 2737
DF2374250
DivK1c_000973
EINECS 216-596-2
HMS2093H22
HMS503C07
HSDB 3265
I14-1364
IDI1_000973
Iktorivil
Jsp003251
KBio1_000973
Kenoket
Klonopin
Klonopin (TN)
Klonopin Rapidly Disintegrating
LS-34156
LS-34260
Landsen
Lktorivil
Lonazep
Melzap
MolPort-001-729-088
NINDS_000973
NIOSH/DF2374250
NSC 179913
NSC179913
Oprea1_168772
Paxam
RO4023
Ravotril
Rivatril
Rivoril
Rivotril
Ro 4-8180
Ro 4023
Ro 5-4023
Ro 5-4023/B-7
Ro 54023
Ro-5-4023
Solfidin
UNII-5PE9FDE8GB
WLN: T67 GMV JN IHJ CNW KR BG
ZINC03813003
clonazepam
18
Lamotrigineapproved, investigationalPhase 4, Phase 3, Phase 2, Phase 117984057-84-13878
Synonyms:
3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine
3,5-Diamino-6-(2,3-dichlorophenyl)-as-triazine
3,5-diamino-6-(2,3-dichlorophenyl)- as -triazine
6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diyldiamine
6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine
84057-84-1
AC-10298
AC1L1GWT
BIDD:GT0794
BW 430C
BW-430C
Bio-0056
C047781
CHEBI:138727
CHEBI:6367
CHEMBL741
CID3878
CPD000058464
Crisomet
D00354
DB00555
Desitin Brand of Lamotrigine
EINECS 281-901-8
EU-0100688
EUR-1048
Faes Brand of Lamotrigine
GI 267119X
GW 273293
Glaxo Wellcome Brand of Lamotrigine
GlaxoSmithKline Brand of Lamotrigine
HMS2051C10
HMS2089M08
HMS2093P21
HSDB 7526
Juste Brand of Lamotrigine
L 3791
L3791_SIGMA
LS-155249
 
Labileno
Lamictal
Lamictal (TN)
Lamictal CD
Lamictal Cd
Lamictal ODT
Lamictal XR
Lamictin
Lamiktal
Lamitor
Lamotrigina
Lamotrigina [Spanish]
Lamotrigine
Lamotrigine (JAN/USAN/INN)
Lamotrigine [USAN:INN:BAN]
Lamotriginum
Lamotriginum [Latin]
Lopac-L-3791
Lopac0_000688
MLS000069685
MLS000759486
MLS001077325
MolPort-003-666-744
NCGC00015605-01
NCGC00015605-02
NCGC00015605-06
NCGC00015605-08
NCGC00022936-02
NCGC00022936-04
NCGC00022936-05
NSC746307
SAM001246697
SMP2_000303
SMR000058464
STK628377
Tocris-1611
UNII-U3H27498KS
ZINC00013156
lamotrigine
19
Propofolapproved, investigationalPhase 4, Phase 39312078-54-84943
Synonyms:
2, 6-Diisopropylphenol
2,6 Diisopropylphenol
2,6-Bis(1-methylethyl)phenol
2,6-Bis(Isopropyl)-phenol
2,6-DIISOPROPYLPHENOL
2,6-Diisopropyl phenol
2,6-Diisopropylphenol
2,6-bis(1-methylethyl)-phenol
2,6-di(propan-2-yl)phenol
2078-54-8
28449-97-0
4-06-00-03435 (Beilstein Handbook Reference)
50356-15-5
AB00513968
AC-2038
AC1L1J9Y
AC1Q1OUI
AI3-26295
AM-149
Abbott Brand of Propofol
Alpha Brand of Propofol
Ampofol
Aquafol
Astra Brand of Propofol
AstraZeneca Brand of Propofol
BIDD:GT0436
BPBio1_000950
BPBio1_000969
BRD-K82255054-001-03-5
BRN 1866484
BSPBio_000862
Biomol-NT_000248
Braun Brand of Propofol
C07523
C12H18O
CAS-2078-54-8
CCRIS 9000
CHEBI:44915
CHEMBL526
CID4943
CPD-11437
CPD000059151
Curamed Brand of Propofol
D00549
D015742
D0617
D126608
D126608_ALDRICH
DB00818
DDS-04F
Diisopropylphenol
Dipravan
Diprivan
Diprivan (TN)
Diprivan Injectable emulsion
Disoprivan
Disoprofol
EINECS 218-206-6
EU-0100437
Fresenius Brand of Propofol
Fresenius Kabi Brand of Propofol
Fresofol
HMS1570L04
HMS2089O21
HMS2094E17
 
HSDB 7123
ICI 35,868
ICI 35868
ICI-35,868
ICI-35868
ICI35,868
ICI35868
InChI=1/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H
Ivofol
Jsp004266
Juste Brand of Propofol
LS-996
Lopac-D126608
Lopac0_000437
MLS001066348
MLS001335999
MLS002454360
MolPort-001-794-517
NCGC00015389-01
NCGC00015389-02
NCGC00015389-04
NCGC00015389-09
NCGC00091538-01
NCGC00091538-02
NCGC00091538-03
NCGC00091538-04
NCGC00091538-05
NCGC00091538-06
NSC 5105
NSC5105
PFL
Parnell Brand of Propofol
Pisa Brand of Propofol
Prestwick0_000931
Prestwick1_000931
Prestwick2_000931
Prestwick3_000931
Propofol
Propofol (JAN/USAN/INN)
Propofol Abbott
Propofol Fresenius
Propofol IDD-D
Propofol MCT
Propofol Rovi
Propofol [USAN:INN:BAN]
Propofol(2,6-Diisopropylphenol)
Propofol-Lipuro
Propofolum
Propofolum [Latin]
Rapinovet
Recofol
Rovi Brand of Propofol
S01-0189
SAM002264610
SMR000059151
SPBio_003031
SPECTRUM1505022
ST50405911
Schering Brand of Propofol
UNII-YI7VU623SF
W505102_ALDRICH
ZD-0859
ZINC00968303
Zeneca Brand of Propofol
ghl.PD_Mitscher_leg0.558
nchembio.552-comp7
propofol
20
VigabatrinapprovedPhase 4, Phase 31960643-86-95665
Synonyms:
( inverted question mark)-gamma-Vinyl GABA
(?)-gamma-Vinyl GABA
(R,S)-4-Amino-5-hexenoic acid
.gamma.-Vinyl-.gamma.-aminobutyric acid
.gamma.-Vinyl-GABA
4-Amino-5-hexenoic acid
4-Aminohexenoic acid
4-aminohex-5-enoic acid
60643-86-9
74046-07-4
AB00053309
AC1L1KUZ
Acid, gamma-Vinyl-gamma-Aminobutyric
Aventis Brand of Vigabatrin
BPBio1_000465
BPBio1_000925
BSPBio_000421
BSPBio_003469
Biomol-NT_000247
C07500
C6H11NO2
CHEBI:241484
CHEMBL89598
CID5665
CPP-109
D00535
D020888
DB01080
DivK1c_006760
EU-0101277
GVG
HMS1569F03
HMS2094M21
Hexenoic acid, 4-amino
Hoechst Brand of Vigabatrin
KBio1_001704
KBio2_000848
KBio2_003416
KBio2_005984
KBio3_002973
KBioSS_000848
LS-75569
Lopac0_001277
M071754
MDL 71,754
MDL 71754
 
MDL-71754
MolPort-003-666-796
NCGC00016087-03
NCGC00016087-08
NCGC00024802-02
NCGC00024802-03
NCGC00024802-04
NCGC00024802-05
NCGC00024802-06
Prestwick0_000501
Prestwick1_000501
Prestwick2_000501
Prestwick3_000501
Prestwick_837
RMI 71754
RMI-71754
RMI-71890
SPBio_002342
SPECTRUM1502036
Sabril
Sabril (TN)
Sabrilex
SpecPlus_000664
Spectrum3_001825
Spectrum_000368
V 8261
V8261_SIGMA
Vigabatrin
Vigabatrin (JAN/USAN/INN)
Vigabatrin Aventis Brand
Vigabatrin Hoechst Brand
Vigabatrin Yamanouchi Brand
Vigabatrin [USAN:BAN:INN]
Vigabatrin [USAN:INN:BAN]
Vigabatrina
Vigabatrina [Spanish]
Vigabatrine
Vigabatrine [French]
Vigabatrinum
Vigabatrinum [Latin]
Yamanouchi Brand of Vigabatrin
gamma Vinyl GABA
gamma Vinyl gamma Aminobutyric Acid
gamma-Vinyl GABA
gamma-Vinyl-GABA
gamma-Vinyl-gamma-Aminobutyric Acid
gamma-Vinyl-gamma-aminobutyric acid
vigabatrin
21
butyric acidexperimentalPhase 4292107-92-6264
Synonyms:
1-Butanoate
1-Butanoic acid
1-Butyrate
1-Butyric acid
1-Propanecarboxylate
1-Propanecarboxylic acid
Butanate
Butanic acid
Butanoate
Butanoic acid
Buttersaeure
Butyrate
 
Butyric acid
Ethylacetate
Ethylacetic acid
Honey robber
Kyselina maselna
N-Butanoate
N-Butanoic acid
N-Butyrate
N-Butyric acid
Propanecarboxylate
Propanecarboxylic acid
Propylformate
Propylformic acid
22Dopamine AgentsPhase 4, Phase 23084
23Dopamine Uptake InhibitorsPhase 4925
24Serotonin Uptake InhibitorsPhase 4, Phase 3, Phase 21369
25
SerotoninPhase 4, Phase 3, Phase 2314750-67-95202
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
 
5-Hydroxy-tryptamine
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
Antemovis
DS substance
Enteramin
Enteramine
26Central Nervous System StimulantsPhase 41721
27Serotonin AgentsPhase 4, Phase 3, Phase 22668
28Pharmaceutical SolutionsPhase 4, Phase 3, Phase 1, Phase 27004
29Anesthetics, IntravenousPhase 4, Phase 3, Phase 2, Phase 11943
30GABA ModulatorsPhase 4, Phase 3, Phase 2, Phase 1657
31Hypnotics and SedativesPhase 4, Phase 3, Phase 2, Phase 12032
32AnticonvulsantsPhase 4, Phase 3, Phase 2, Phase 12249
33Anesthetics, GeneralPhase 4, Phase 3, Phase 2, Phase 12274
34Trace ElementsPhase 4, Phase 3, Phase 23900
35Antihypertensive AgentsPhase 43618
36Muscarinic AntagonistsPhase 4961
37
Eslicarbazepine acetatePhase 4, Phase 36275970-99-9123618
Synonyms:
10-Acetoxy-10,11-dihydro-5H-dibenz(b,f)azepine-5-carboxamide
236395-14-5
AC1L452K
AKOS005145781
B5435_SIGMA
BIA 2-093
BIA-2-093
CHEBI:239940
CHEMBL87992
CID179344
Erelib
 
Eslicarbazepine acetate
Exalief
MolPort-005-942-413
NCGC00165752-01
NCGC00165752-02
Pazzul
S-(-)-10-Acetoxy-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide
SEP-0002093
Stedesa
ZINC00007295
Zebinix
[(5S)-11-carbamoyl-5,6-dihydrobenzo[b][1]benzazepin-5-yl] acetate
38MicronutrientsPhase 4, Phase 3, Phase 23901
39AnestheticsPhase 4, Phase 3, Phase 2, Phase 17385
40ParasympatholyticsPhase 4902
41Anti-Obesity AgentsPhase 4, Phase 3, Phase 2, Phase 1354
42Sodium Channel BlockersPhase 4, Phase 3, Phase 2, Phase 11180
43EtiracetamPhase 4, Phase 3, Phase 2196
44Nootropic AgentsPhase 4, Phase 3, Phase 2604
45AnalgesicsPhase 4, Phase 3, Phase 29358
46PiracetamPhase 4, Phase 3, Phase 21367491-74-9
47Neurotransmitter AgentsPhase 4, Phase 3, Phase 2, Phase 114795
48Excitatory Amino AcidsPhase 4, Phase 3, Phase 11109
49calcium channel blockersPhase 4, Phase 3, Phase 11743
50Protective AgentsPhase 4, Phase 3, Phase 2, Phase 15651

Interventional clinical trials:

(show top 50)    (show all 323)
idNameStatusNCT IDPhase
1A Study to Evaluate the Dosing, Effectiveness and Safety of Topiramate for the Treatment of EpilepsyCompletedNCT00266604Phase 4
2Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New DrugCompletedNCT00043901Phase 4
3The Effects on Cognitive Function of Levetiracetam (Keppra®) Compared to Carbamazepine (Tegretol®, Carmazepine®) as Monotherapy for Children With Partial Seizure; A Multicentric Randomized Controlled StudyCompletedNCT02208492Phase 4
4A Study to Assess Tolerability and Efficacy of Topiramate Monotherapy in Recently Diagnosed Patients With EpilepsyCompletedNCT01689649Phase 4
5Non-Interventional Study With LYRICA (Pregabalin) In Patients With Epilepsy As Adjunctive Therapy Of Partial Seizures To Reduce Seizure FrequencyCompletedNCT00684424Phase 4
6Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial EpilepsyCompletedNCT01498822Phase 4
7A Prospective, Observational Study On The Effectiveness Of New Antiepileptic Drugs As First Bitherapy In The Daily Clinical PracticeCompletedNCT00855738Phase 4
8Trial of Levetiracetam in Patients With Primary Brain Tumors and Symptomatic Seizures Who Undergo SurgeryCompletedNCT00571155Phase 4
9Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial SeizuresCompletedNCT00537940Phase 4
10Escitalopram Treatment of Major Depression in Patients With Temporal Lobe EpilepsyCompletedNCT00595699Phase 4
11Methylphenidate for Treating Attention Deficit Hyperactivity Disorder in Children With Both ADHD and EpilepsyCompletedNCT00323947Phase 4
12A Study to Evaluate the Safety and Efficacy of Zonisamide an Antiepileptic Drug as Monotherapy or Adjunctive Therapy in Treatment of Adult Patients With Partial, Generalized or Combined Seizures.CompletedNCT01283256Phase 4
13A Pilot Study to Evaluate Efficacy and Safety of Clevidipine in Neurosurgical PatientsCompletedNCT00952081Phase 4
14Treatments for Psychogenic Nonepileptic Seizures (NES)CompletedNCT00159965Phase 4
15Lyrica (Pregabalin) Administered as an Add-on Therapy for Partial Seizures (LEADER).CompletedNCT00288639Phase 4
16Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly PatientsCompletedNCT01422720Phase 4
17Switching From an SSRI to Tiagabine(GABITRIL) in Order to Alleviate SSRI Induced Sexual DysfunctionCompletedNCT00174850Phase 4
18Comparative Study of Zonisamide and Carbamazepine as an Initial Monotherapy: Efficacy and Safety EvaluationCompletedNCT01127256Phase 4
19Open Label, Zonegran (Zonisamide) In Partial Onset SeizuresCompletedNCT00215592Phase 4
20Modified Atkins Diet Treatment for Adults With Drug-resistant EpilepsyRecruitingNCT01311440Phase 4
21Evaluation of Neuroinflammation in Children With Infantile SpasmsRecruitingNCT02092883Phase 4
22Trial Evaluating the Efficacy and Safety of Perampanel Added to Monotherapy in Participants With Partial Onset SeizuresRecruitingNCT02726074Phase 4
23Topiramate Treatment for Patients With Epilepsy and Learning Disability : A Prospective Observational StudyRecruitingNCT00956696Phase 4
24Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or PlaceboRecruitingNCT00351611Phase 4
25UCB Antiepileptic Drugs (AED) Pregnancy Registry (Formerly the Keppra® Pregnancy Registry)Active, not recruitingNCT00345475Phase 4
26Comparison of Oral 30 % Dextrose and iv Midazolam Sedation During MRI in NeonatesActive, not recruitingNCT02645279Phase 4
27The Benefit of Prophylactic Anticonvulsant in Post Cardiac Arrest Syndrome With Induced Mild HypothermiaEnrolling by invitationNCT01083784Phase 4
28Study to Investigate Dosage, Efficacy, and Safety of Perampanel Given as Monotherapy in Patients With EpilepsyNot yet recruitingNCT02736162Phase 4
29Study Comparing Best Medical Practice With or Without VNS Therapy in Pharmacoresistant Partial Epilepsy PatientsTerminatedNCT00522418Phase 4
30Does Pregabalin Improve Symptoms of Anxiety in Patients With Epilepsy? A Comparison With SertralineTerminatedNCT01309074Phase 4
31Trial to Assess Vagus Nerve Stimulation Therapy vs. Anti-Epileptic Drug (AED) Treatment in Children With Refractory SeizuresTerminatedNCT01118455Phase 4
32Pregabalin In Partial Seizures (PREPS): An Open-Label, Multicenter Add On Therapy TrialTerminatedNCT00407797Phase 4
33An Open-Label, Single and Multiple Oral Dose Pharmacokinetic Study of Vigabatrin in Infants With Infantile SpasmsWithdrawnNCT01413711Phase 4
34Study to Evaluate the Safety and Efficacy of Levetiracetam in Patients Suffering From Idiopathic Generalized Epilepsy With Primary Generalized Tonic-clonic SeizuresCompletedNCT00160550Phase 3
35Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized EpilepsyCompletedNCT00150748Phase 3
36Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy PatientsCompletedNCT00236886Phase 3
37A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent EpilepsyCompletedNCT00231556Phase 3
38Levetiracetam as add-on Treatment of Myoclonic Jerks in Adolescents + AdultsCompletedNCT00150774Phase 3
39Efficacy and Safety of Vanquix for the Management of Selected, Refractory, Patients With Epilepsy Who Require Intermittent Caregiver Medical Intervention to Control Episodes of Acute Repetitive Seizures.CompletedNCT00319501Phase 3
40Clobazam in Patients With Lennox-Gastaut SyndromeCompletedNCT00518713Phase 3
41Monotherapy With Levetiracetam in Newly Diagnosed Patients Suffering From EpilepsyCompletedNCT00150735Phase 3
42Brivaracetam as add-on Treatment in Adolescents and Adults Suffering From EpilepsyCompletedNCT00504881Phase 3
43Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) SeizuresCompletedNCT00104416Phase 3
44Effect of Brivaracetam (BRV) on Nonpsychotic Behavioral Side Effects in Subjects Treated Previously With Levetiracetam (LEV)CompletedNCT01653262Phase 3
45Monotherapy With Levetiracetam in Patients Suffering From Epilepsy.CompletedNCT00150813Phase 3
46Monotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy.CompletedNCT00150787Phase 3
47Clinical Study of Lamotrigine to Treat Newly Diagnosed Typical Absence Seizure in Children and AdolescentsCompletedNCT01431976Phase 3
48Use of the Modified Atkins Diet in Infantile SpasmsCompletedNCT01006811Phase 2, Phase 3
49Prednisolone in Infantile Spasms- High Dose Versus Usual DoseCompletedNCT01575639Phase 3
50A Double-blind, Placebo-controlled Study of Levetiracetam in Epilepsy Patients With Generalized Tonic-clonic Seizures (Except Partial Seizures Evolving to Secondarily Generalized Seizures)CompletedNCT01228747Phase 3

Search NIH Clinical Center for Idiopathic Generalized Epilepsy


Cochrane evidence based reviews: epilepsy, generalized

Genetic Tests for Idiopathic Generalized Epilepsy

About this section

Anatomical Context for Idiopathic Generalized Epilepsy

About this section

MalaCards organs/tissues related to Idiopathic Generalized Epilepsy:

33
Brain, Breast, Temporal lobe, Lung, Testes, Prostate, Thyroid

Animal Models for Idiopathic Generalized Epilepsy or affiliated genes

About this section

MGI Mouse Phenotypes related to Idiopathic Generalized Epilepsy:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053777.6CACNB4, GABRA1, GABRB3, GABRD, KCNJ10
2MP:00053897.2CACNB4, CLCN2, GABRA1, GABRB3, GABRD, GABRG2
3MP:00053786.2CACNA1H, CACNB4, GABRA1, GABRB3, GABRG2, KCNJ10
4MP:00107685.7CACNB4, CHRNA4, GABRA1, GABRB3, GABRD, GABRG2
5MP:00053865.0CACNA1H, CACNB4, CHRNA4, CLCN2, EFHC1, GABRA1
6MP:00036315.0CACNA1H, CACNB4, CHRNA4, CLCN2, EFHC1, GABRA1

Publications for Idiopathic Generalized Epilepsy

About this section

Articles related to Idiopathic Generalized Epilepsy:

(show top 50)    (show all 296)
idTitleAuthorsYear
1
Selective EEG activation by the Stroop test in idiopathic generalized epilepsy. (25735886)
2015
2
Determination of haptoglobin genotype in an Iranian population with idiopathic generalized epilepsy. (26989737)
2015
3
Idiopathic generalized epilepsy and hypokalemic periodic paralysis in a family of South Indian descent. (25893123)
2015
4
Narcolepsy Type 1 and Idiopathic Generalized Epilepsy: Diagnostic and Therapeutic Challenges in Dual Cases. (26156948)
2015
5
Identifying Corticothalamic Network Epicenters in Patients with Idiopathic Generalized Epilepsy. (25907518)
2015
6
Investigation of glutamine and GABA levels in patients with idiopathic generalized epilepsy using MEGAPRESS. (24585443)
2014
7
Rare exonic deletions of the RBFOX1 gene increase risk of idiopathic generalized epilepsy. (23350840)
2013
8
Idiopathic generalized epilepsy: Phenotypic and electroencephalographic observations in a large cohort from South India. (23956556)
2013
9
Neuropsychological and psychiatric outcomes in poorly controlled idiopathic generalized epilepsy. (23832134)
2013
10
Accelerated long-term forgetting in children with idiopathic generalized epilepsy. (23061735)
2012
11
The electroencephalogram of idiopathic generalized epilepsy. (22150583)
2012
12
Glucose transporter 1 deficiency in the idiopathic generalized epilepsies. (23280796)
2012
13
Acute psychosis during the postictal period in a patient with idiopathic generalized epilepsy: postictal psychosis or aggravation of schizophrenia? A case report and review of the literature. (22652424)
2012
14
GABAergic neuron deficit as an idiopathic generalized epilepsy mechanism: the role of BRD2 haploinsufficiency in juvenile myoclonic epilepsy. (21887291)
2011
15
EEG functional connectivity of the intrahemispheric cortico-cortical network of idiopathic generalized epilepsy. (21601428)
2011
16
Altered functional-structural coupling of large-scale brain networks in idiopathic generalized epilepsy. (21975588)
2011
17
Distinct white matter abnormalities in different idiopathic generalized epilepsy syndromes. (22092238)
2011
18
The effective and ethical use of voluntary induction of psychogenic drop attacks in a patient with idiopathic generalized epilepsy. (20236869)
2010
19
Dimorphism of TAP-1 gene in Caucasian with juvenile myoclonic epilepsy and in Tunisian with idiopathic generalized epilepsies. (20141545)
2010
20
Valproate in children with newly diagnosed idiopathic generalized epilepsy. (20055770)
2010
21
CLCN2 variants in idiopathic generalized epilepsy. (19710712)
2009
22
Idiopathic generalized epilepsy (IGE) syndromes in development: IGE with absences of early childhood, IGE with phantom absences, and perioral myoclonia with absences. (19469842)
2009
23
EEG features of absence seizures in idiopathic generalized epilepsy: impact of syndrome, age, and state. (19243419)
2009
24
Efficacy and tolerability of zonisamide in idiopathic generalized epilepsy. (19264587)
2009
25
Association of idiopathic generalized epilepsy with polymorphisms in the neuronal nicotinic acetylcholine receptor subunits. (17385675)
2007
26
Lack of evidence of an allelic association of a functional GABRB3 exon 1a promoter polymorphism with idiopathic generalized epilepsy. (17215107)
2007
27
Extended spectrum of idiopathic generalized epilepsies associated with CACNA1H functional variants. (17696120)
2007
28
Idiopathic generalized epilepsy phenotypes associated with different EFHC1 mutations. (17159113)
2006
29
Coexistence of focal and idiopathic generalized epilepsy in the same patient population. (16352448)
2006
30
Malic enzyme 2 may underlie susceptibility to adolescent-onset idiopathic generalized epilepsy. (15532013)
2005
31
Tonic status epilepticus in patients with idiopathic generalized epilepsy. (16338675)
2005
32
Management guidelines for children with idiopathic generalized epilepsy. (16302884)
2005
33
Imaging idiopathic generalized epilepsy. (15493530)
2004
34
Exploration of a putative susceptibility locus for idiopathic generalized epilepsy on chromosome 8p12. (12581227)
2003
35
Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies. (12612585)
2003
36
Linguistic processing in idiopathic generalized epilepsy: an auditory event-related potential study. (12919393)
2003
37
EEG discharges on awakening: a marker of idiopathic generalized epilepsy. (11148252)
2001
38
Association analysis between a regulatory-promoter polymorphism of the human monoamine oxidase A gene and idiopathic generalized epilepsy. (10759301)
2000
39
The voltage-gated sodium channel beta2-subunit gene and idiopathic generalized epilepsy. (10976944)
2000
40
Length variation of a polyglutamine array in the gene encoding a small-conductance, calcium-activated potassium channel (hKCa3) and susceptibility to idiopathic generalized epilepsy. (10094433)
1999
41
Quantitative MRI in patients with idiopathic generalized epilepsy. Evidence of widespread cerebral structural changes. (9762955)
1998
42
Primary (idiopathic) generalized epilepsy and underlying mechanisms. (8719497)
1996
43
Wavelength specificity of photoparoxysmal responses in idiopathic generalized epilepsy. (7588452)
1995
44
Disturbance of visual information processing in temporal lobe epilepsy: in comparison with idiopathic generalized epilepsy. (8271589)
1993
45
Linkage analysis of idiopathic generalized epilepsy (IGE) and marker loci on chromosome 6p in families of patients with juvenile myoclonic epilepsy: no evidence for an epilepsy locus in the HLA region. (8352275)
1993
46
Distinctive characteristics of frontal lobe epilepsy versus idiopathic generalized epilepsy. (1543069)
1992
47
Localization of idiopathic generalized epilepsy on chromosome 6p in families of juvenile myoclonic epilepsy patients. (1922810)
1991
48
49
50

Variations for Idiopathic Generalized Epilepsy

About this section

Expression for genes affiliated with Idiopathic Generalized Epilepsy

About this section
Search GEO for disease gene expression data for Idiopathic Generalized Epilepsy.

Pathways for genes affiliated with Idiopathic Generalized Epilepsy

About this section

Pathways related to Idiopathic Generalized Epilepsy according to GeneCards Suite gene sharing:

(show all 18)
idSuper pathwaysScoreTop Affiliating Genes
19.9CACNA1H, CACNB4
2
Show member pathways
9.7GABRA1, GABRG2
3
Show member pathways
9.5CACNB4, SCN1A, SCN1B
4
Show member pathways
9.3KCNJ10, KCNQ2, KCNQ3
59.3CACNA1H, CACNB4, KCNQ2, KCNQ3
6
Show member pathways
9.2KCNQ2, KCNQ3, SCN1A, SCN1B
79.2KCNQ2, KCNQ3, SCN1A, SCN1B
89.0CACNB4, KCNJ10, KCNQ2, KCNQ3
9
Show member pathways
8.9GABRA1, GABRB3, GABRG2
10
Show member pathways
8.6CACNA1H, CACNB4, KCNQ2, KCNQ3, SCN1A, SCN1B
11
Show member pathways
8.4CLCN2, GABRA1, GABRB3, GABRG2
12
Show member pathways
8.4GABRA1, GABRB3, GABRG2, KCNJ10
138.3GABRA1, GABRB3, GABRD, GABRG2
14
Show member pathways
8.3GABRA1, GABRB3, GABRD, GABRG2
157.9CHRNA4, GABRA1, GABRB3, GABRD, GABRG2
16
Show member pathways
7.7CACNA1H, CACNB4, GABRA1, GABRB3, GABRD, GABRG2
17
Show member pathways
7.1CACNB4, CHRNA4, GABRA1, GABRB3, GABRG2, KCNJ10
18
Show member pathways
6.8CACNA1H, CHRNA4, GABRA1, GABRB3, GABRD, GABRG2

GO Terms for genes affiliated with Idiopathic Generalized Epilepsy

About this section

Cellular components related to Idiopathic Generalized Epilepsy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1voltage-gated potassium channel complexGO:00080769.9KCNQ2, KCNQ3
2intercalated discGO:00147049.5SCN1A, SCN1B

Biological processes related to Idiopathic Generalized Epilepsy according to GeneCards Suite gene sharing:

(show all 10)
idNameGO IDScoreTop Affiliating Genes
1synaptic transmission, GABAergicGO:005193210.4GABRA1, GABRG2
2membrane depolarization during action potentialGO:008601010.3CACNA1H, SCN1A
3adult walking behaviorGO:000762810.1CACNB4, KCNJ10
4cardiac conductionGO:006133710.1CACNB4, SCN1B
5neuronal action potential propagationGO:001922710.1CACNB4, SCN1A, SCN1B
6axon guidanceGO:00074119.1CACNA1H, CACNB4, KCNQ2, SCN1B
7regulation of membrane potentialGO:00423918.9CACNA1H, CACNB4, CHRNA4, KCNJ10
8transmembrane transportGO:00550858.6CACNA1H, GABRA1, GABRB3, GABRG2, SCN1A
9transportGO:00068107.9CACNA1H, CACNB4, CHRNA4, CLCN2, GABRB3
10ion transportGO:00068117.3CHRNA4, GABRA1, GABRB3, GABRD, KCNQ2, KCNQ3

Molecular functions related to Idiopathic Generalized Epilepsy according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1extracellular ligand-gated ion channel activityGO:00052309.5CHRNA4, GABRD
2GABA-A receptor activityGO:00048908.5GABRA1, GABRB3, GABRD

Sources for Idiopathic Generalized Epilepsy

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet